STOCK TITAN

Cevian holds 9.6% of Smith & Nephew (NYSE: SNN) shares

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Cevian Capital II GP LTD filed Amendment No. 4 to its Schedule 13D on Smith & Nephew plc, reporting beneficial ownership of 81,687,136 ordinary shares, equal to 9.6% of the outstanding shares. Cevian has sole voting and dispositive power over this entire stake.

Cevian states it bought these shares for the Cevian funds for total consideration of about USD $1,095,708,998, funding the purchases from the funds’ general working capital and paying in British pounds, using an exchange rate of USD $1.32385 per GBP 1.00. The 9.6% figure is based on 849,889,305 ordinary shares outstanding as of February 28, 2026, as reported by the issuer on Form 6-K filed on March 2, 2026.

Positive

  • None.

Negative

  • None.

Insights

Cevian discloses a sizable 9.6% stake in Smith & Nephew.

Cevian Capital II GP LTD reports beneficial ownership of 81,687,136 Smith & Nephew ordinary shares, representing 9.6% of the company. All of these shares are under Cevian’s sole voting and dispositive control, indicating a consolidated position rather than fragmented holdings.

The filing shows that Cevian funds spent roughly USD $1,095,708,998 to build the stake, funded from their general working capital and executed in British pounds at USD $1.32385 per GBP. The ownership percentage is calculated against 849,889,305 shares outstanding as of February 28, 2026, tying the stake directly to the company’s reported share count.

This amendment primarily updates ownership and funding details and references recent trading activity in Schedule B. It does not itself specify strategic intentions, so any implications for Smith & Nephew will depend on future disclosures or actions associated with this 9.6% holding.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D


Cevian Capital II GP LTD
Signature:/s/ Norma O'Sullivan
Name/Title:Norma O'Sullivan, Director
Date:03/16/2026

FAQ

How much of Smith & Nephew (SNN) does Cevian Capital now own?

Cevian Capital II GP LTD reports beneficial ownership of 81,687,136 Smith & Nephew ordinary shares, representing 9.6% of the outstanding shares. The percentage is based on 849,889,305 shares reported outstanding as of February 28, 2026 in a Form 6-K.

What did Cevian Capital pay for its Smith & Nephew (SNN) stake?

Cevian states its funds purchased 81,687,136 ordinary shares for total consideration of about USD $1,095,708,998, including brokerage commissions. The purchases were made in British pounds, using an exchange rate of USD $1.32385 per GBP 1.00 for reporting purposes.

How is Cevian’s ownership percentage in Smith & Nephew (SNN) calculated?

The reported 9.6% ownership is based on 849,889,305 ordinary shares outstanding as of February 28, 2026. That share count comes from Smith & Nephew’s Report of Foreign Private Issuer on Form 6-K filed with the SEC on March 2, 2026.

What voting and disposal rights does Cevian have over its Smith & Nephew (SNN) shares?

Cevian Capital II GP LTD reports sole voting power and sole dispositive power over all 81,687,136 ordinary shares. It reports no shared voting or shared dispositive power, meaning decisions over voting and selling these shares rest solely with Cevian for this stake.

How did Cevian fund its investment in Smith & Nephew (SNN)?

Cevian explains that its funds acquired the 81,687,136 ordinary shares using their general working capital. The shares were purchased in British pounds, and for reporting they used an exchange rate of USD $1.32385 per GBP 1.00 to state the approximate dollar cost.

What does Amendment No. 4 to Cevian’s Schedule 13D on Smith & Nephew cover?

Amendment No. 4 updates and restates Items 3 and 5(a)-(c) of Cevian’s prior Schedule 13D. It details the source and amount of funds, the 81,687,136 shares beneficially owned, the 9.6% stake, and recent share transactions referenced in Schedule B.
Smith & Nephew

NYSE:SNN

View SNN Stock Overview

SNN Rankings

SNN Latest News

SNN Latest SEC Filings

SNN Stock Data

13.99B
424.89M
Medical Devices
Healthcare
Link
United Kingdom
Watford